Meredith A. Morgan

9.4k total citations · 2 hit papers
86 papers, 5.1k citations indexed

About

Meredith A. Morgan is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Meredith A. Morgan has authored 86 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 44 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Meredith A. Morgan's work include DNA Repair Mechanisms (25 papers), PARP inhibition in cancer therapy (20 papers) and Pancreatic and Hepatic Oncology Research (19 papers). Meredith A. Morgan is often cited by papers focused on DNA Repair Mechanisms (25 papers), PARP inhibition in cancer therapy (20 papers) and Pancreatic and Hepatic Oncology Research (19 papers). Meredith A. Morgan collaborates with scholars based in United States, China and Israel. Meredith A. Morgan's co-authors include Theodore S. Lawrence, Michael H. Gold, Jeffrey K. Glenn, Masaaki Kuwahara, Leslie A. Parsels, Jonathan Maybaum, Joshua D. Parsels, Yi Sun, Mary B. Mayfield and Lili Zhao and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Meredith A. Morgan

84 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Separation and characterization of two extracelluar H₂O₂‐dependent oxidases from ligninolytic cultures of Phanerochaete chrysosporium

1984 662 citations Meredith A. Morgan et al. profile →
An extracellular H2O2-requiring enzyme preparation involved in lignin biodegradation by the white rot basidiomycete Phanerochaete chrysosporium

1983 469 citations Meredith A. Morgan et al. profile →

Peers

Countries citing papers authored by Meredith A. Morgan

Since Specialization

Citations

This map shows the geographic impact of Meredith A. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith A. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith A. Morgan more than expected).

Fields of papers citing papers by Meredith A. Morgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith A. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith A. Morgan. The network helps show where Meredith A. Morgan may publish in the future.

Co-authorship network of co-authors of Meredith A. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Meredith A. Morgan. A scholar is included among the top collaborators of Meredith A. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith A. Morgan. Meredith A. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer 2024 ·JCI Insight ·(unknown), Long Jiang, Weiwei Wang, Amanda K. Huber, (unknown), (unknown), Erin A. Holcomb, (unknown), Stephanie The, Zhuwen Wang, Leslie A. Parsels, Joshua D. Parsels, Daniel Wahl, Arvind Rao, Vaibhav Sahai, Theodore S. Lawrence, Michael D. Green, Meredith A. Morgan	7
2	Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner 2021 ·Molecular Cancer Research ·Kailiang Zhao, Qiang Zhang, (unknown), Xueting Lang, Long Jiang, Leslie A. Parsels, Joshua D. Parsels, Weiping Zou, Theodore S. Lawrence, Rémi Buisson, Michael D. Green, Meredith A. Morgan	10
3	Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination–Proficient Pancreatic Cancer 2020 ·Molecular Cancer Therapeutics ·Leslie A. Parsels, Carl G. Engelke, Joshua D. Parsels, (unknown), Qiang Zhang, Daria M. Tanska, Daniel Wahl, Christine E. Canman, Theodore S. Lawrence, Meredith A. Morgan	29
4	Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy 2019 ·Cancer Research ·Qiang Zhang, Michael D. Green, Xueting Lang, Jenny Lazarus, Joshua D. Parsels, Shuang Wei, Leslie A. Parsels, Jiaqi Shi, Nithya Ramnath, Daniel Wahl, Marina Pasca di Magliano, Timothy L. Frankel, Ilona Kryczek, Yu L. Lei, Theodore S. Lawrence, Weiping Zou, Meredith A. Morgan	150
5	PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors 2017 ·Molecular Cancer Research ·Leslie A. Parsels, David Karnak, Joshua D. Parsels, Qiang Zhang, (unknown), Zachery R. Reichert, Daniel Wahl, Jonathan Maybaum, Mark J. O’Connor, Theodore S. Lawrence, Meredith A. Morgan	98
6	Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma 2017 ·Cancer Biotherapy and Radiopharmaceuticals ·Peter L. Roberson, Lauren B. Smith, Meredith A. Morgan, Matthew J. Schipper, S.J. Wilderman, Anca M. Avram, Mark Kaminski, Yuni K. Dewaraja	1
7	Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis 2016 ·Cancer Research ·Daniel Wahl, Joseph Dresser, Kari Wilder-Romans, Joshua D. Parsels, Shuang G. Zhao, Mary A. Davis, Lili Zhao, Maureen Kachman, Stefanie Wernisch, Charles Burant, Meredith A. Morgan, Felix Y. Feng, Corey Speers, Costas A. Lyssiotis, Theodore S. Lawrence	67
8	Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas 2015 ·Clinical Cancer Research ·Edgar Ben‐Josef, (unknown), William F. Regine, Ross A. Abrams, Meredith A. Morgan, Dafydd G. Thomas, Paul Schaefer, Thomas A. DiPetrillo, Mitchel Fromm, William Small, Samir Narayan, Kathryn Winter, Kent A. Griffith, Chandan Guha, Terence M. Williams	5
9	Combined Inhibition of Wee1 and PARP1/2 for Radiosensitization in Pancreatic Cancer 2014 ·Clinical Cancer Research ·David Karnak, Carl G. Engelke, Leslie A. Parsels, Tasneem Kausar, Dongping Wei, (unknown), (unknown), Mary A. Davis, Lili Zhao, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan	125
10	Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy 2014 ·Antioxidants and Redox Signaling ·Yongchao Zhao, Meredith A. Morgan, Yi Sun	198
11	Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair 2013 ·Clinical Cancer Research ·Dongping Wei, Leslie A. Parsels, David Karnak, Mary A. Davis, Joshua D. Parsels, (unknown), Lili Zhao, Jonathan Maybaum, Theodore S. Lawrence, Yi Sun, Meredith A. Morgan	80
12	Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776 2013 ·Clinical Cancer Research ·Carl G. Engelke, Leslie A. Parsels, Yushen Qian, Qiang Zhang, David Karnak, (unknown), Daria M. Tanska, Dongping Wei, Mary A. Davis, Joshua D. Parsels, Lili Zhao, Joel K. Greenson, Theodore S. Lawrence, Jonathan Maybaum, Meredith A. Morgan	89
13	MRE11 Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers 2011 ·Cancer Research ·Eduardo Vilar, (unknown), Stephanie L. Stenzel, Leon Raskin, Jaeil Ahn, Vı́ctor Moreno, Bhramar Mukherjee, Maria D. Iniesta, Meredith A. Morgan, Gad Rennert, Stephen B. Gruber	117
14	Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases 2011 ·Molecular Cancer Therapeutics ·Jie Yang, Donna McEachern, Wenyan Li, Mary A. Davis, Hua Li, Meredith A. Morgan, Longchuan Bai, (unknown), Haiying Sun, Theodore S. Lawrence, Shaomeng Wang, Yi Sun	43
15	Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor 2011 ·Cancer Research ·Dongping Wei, Hua Li, Jie Yu, (unknown), Lili Zhao, Theodore S. Lawrence, Peter G. Smith, Meredith A. Morgan, Yi Sun	136
16	Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition 2011 ·Clinical Cancer Research ·Leslie A. Parsels, Yushen Qian, Daria M. Tanska, (unknown), Lili Zhao, Maria Hassan, Sankari Arumugarajah, Joshua D. Parsels, Linda Hylander-Gans, Diane M. Simeone, Deborah Morosini, Jeffrey L. Brown, Sonya Zabludoff, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan	67
17	Bayesian Hierarchical Changepoint Methods in Modeling the Tumor Growth Profiles in Xenograft Experiments 2010 ·Clinical Cancer Research ·Lili Zhao, Meredith A. Morgan, Leslie A. Parsels, Jonathan Maybaum, Theodore S. Lawrence, Daniel P. Normolle	26
18	Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair 2010 ·Cancer Research ·Meredith A. Morgan, Leslie A. Parsels, Lili Zhao, Joshua D. Parsels, Mary A. Davis, Maria Hassan, Sankari Arumugarajah, Linda Hylander-Gans, Deborah Morosini, Diane M. Simeone, Christine E. Canman, Daniel P. Normolle, Sonya Zabludoff, Jonathan Maybaum, Theodore S. Lawrence	249
19	Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells 2009 ·Molecular Cancer Therapeutics ·Leslie A. Parsels, Meredith A. Morgan, Daria M. Tanska, Joshua D. Parsels, Brian D. Palmer, R J Booth, William A. Denny, Christine E. Canman, Alan J. Kraker, Theodore S. Lawrence, Jonathan Maybaum	120
20	The Combination of Epidermal Growth Factor Receptor Inhibitors with Gemcitabine and Radiation in Pancreatic Cancer 2008 ·Clinical Cancer Research ·Meredith A. Morgan, Leslie A. Parsels, (unknown), Daniel P. Normolle, Jonathan Maybaum, Theodore S. Lawrence	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact